Amgen's MariTide showed strong weight loss and metabolic gains in Phase 2, with no new safety signals as Phase 3 trials begin in obesity and T2D.

We are honored to welcome Dr. Kirsch to the IHL-42X Clinical Advisory Board,” stated Dr. Lou Barbato, Incannex Chief Medical Officer. “His extensive clinical experience and leadership within the sleep ...

Once-weekly amycretin, a novel peptide activating GLP-1, amylin, and calcitonin receptors, produced rapid, substantial, and ...

Amgen is expanding development plans for its weight-loss drug MariTide to study its use for heart disease and sleep apnea.

Amgen's weight-loss drug MariTide had a successful Phase 2 trial so the company is expanding development plans to study its use for heart disease and sleep apnea.

Kelsey Sharma, a nurse practitioner based in Minnesota, presents her research on the relationship between OSA, GERD, and IBD ...

And the severe cases — when people stop breathing more than 30 times in a single hour — go up, too. "You also increase the ...

If you have milder symptoms, you may be able to see improvements with natural remedies. For moderate to severe sleep apnea, ...

Expect social and relationships to change after weight loss. The more weight you lose and the more you change your lifestyle to achieve healthy weight loss, the more likely relationships are to change ...

Samsung's newest Galaxy Watches will feature AI-powered sleep and fitness coaching and the first-ever noninvasive blood ...

Obesity involves having too much body fat. According to the Mayo Clinic, obesity becomes a medical problem that increases the risk of many other diseases and health problems.These problems include ...

But stuffy nights might have a more dangerous impact on our rest than we previously realized, as a new wide reaching study ...